Analysts Set ConvaTec Group PLC (LON:CTEC) Price Target at GBX 306

ConvaTec Group PLC (LON:CTEC – Get Free Report) has earned an average rating of “Moderate Buy” from the nine research firms that are presently covering the stock, Marketbeat Ratings reports. One investment analyst has rated the stock with a hold rating and eight have assigned a buy rating to the company. The average twelve-month price objective among brokers that have updated their coverage on the stock in the last year is GBX 306.

CTEC has been the topic of a number of analyst reports. JPMorgan Chase & Co. cut their target price on ConvaTec Group from GBX 307 to GBX 294 and set an “overweight” rating on the stock in a research note on Friday, May 22nd. UBS Group restated a “buy” rating and set a GBX 375 price objective on shares of ConvaTec Group in a report on Monday, May 18th. Royal Bank Of Canada reaffirmed an “outperform” rating and issued a GBX 315 price objective on shares of ConvaTec Group in a research report on Monday, August 3rd. Citigroup cut their price objective on ConvaTec Group from GBX 250 to GBX 230 and set a “neutral” rating on the stock in a research report on Monday, May 18th. Finally, Jefferies Financial Group reiterated a “buy” rating and issued a GBX 300 target price on shares of ConvaTec Group in a research note on Wednesday, August 5th.

Get ConvaTec Group alerts:

Read Our Latest Analysis on CTEC

ConvaTec Group Stock Performance

ConvaTec Group stock opened at GBX 219.60 on Thursday. The company has a debt-to-equity ratio of 121.83, a current ratio of 1.93 and a quick ratio of 0.96. The firm has a market capitalization of £4.26 billion, a P/E ratio of 35.42, a price-to-earnings-growth ratio of 0.93 and a beta of 0.77. ConvaTec Group has a 1-year low of GBX 193 and a 1-year high of GBX 259.30. The company’s 50-day moving average is GBX 224.16 and its 200 day moving average is GBX 221.04.

Insider Activity at ConvaTec Group

In related news, insider Tobias Hestler purchased 50,000 shares of the business’s stock in a transaction dated Thursday, August 6th. The shares were purchased at an average cost of GBX 226 per share, for a total transaction of £113,000. Insiders own 0.98% of the company’s stock.

About ConvaTec Group

(Get Free Report)

ConvaTec Group PLC engages in the development, manufacturing, and sale of medical products, services, and technologies in Europe, North America, and internationally. The company offers advanced wound dressings and skin care products for the management of acute and chronic wounds resulting from various conditions, such as diabetes, and acute conditions resulting from traumatic injury and burns. It also provides ostomy care solutions, including devices, accessories, and services for people with a stoma resulting from colorectal cancer, inflammatory bowel disease, and bladder cancer.

See Also

• Five stocks we like better than ConvaTec Group
• Qualcomm’s Data Center Bet Looks More Real After Amazon’s AI Deal
• GE Aerospace’s $11.75B Deal Puts Howmet Aerospace in Focus
• Casey’s Post-Earnings Drop May Give Investors a Better Entry Into a Quality Retailer
• Sovereign AI: Palantir and Nebius Cut the Cloud Cord

Receive News & Ratings for ConvaTec Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ConvaTec Group and related companies with MarketBeat.com's FREE daily email newsletter.